Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients

Journal of Clinical Microbiology

Volumn 50, Issue 6, 2012, Pages 2034-2039

  Marko, Daniel C ^a   Saffert, Ryan T ^b   Cunningham, Scott A ^b   Hyman, Jay ^c   Walsh, John ^c   Arbefeville, Sophie ^a   Howard, Wanita ^a   Pruessner, Jon ^a   Safwat, Nedal ^c   Cockerill, Franklin R ^b   Bossler, Aaron D ^a   Patel, Robin ^b   Richter, Sandra S ^d  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

^b MAYO CLINIC   (United States)

^c BIOMÉRIEUX   (France)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

ACHROMOBACTER; ACHROMOBACTER XYLOSOXIDANS; ARTICLE; BACILLI; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BORDETELLA BRONCHISEPTICA; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA GLADIOLI; CAPNOCYTOPHAGA GINGIVALIS; CAPNOCYTOPHAGA SPUTIGENA; CELLULOMONAS; CELLULOMONAS HOMINIS; CHEMICAL ANALYSIS; CHRYSEOBACTERIUM; CHRYSEOBACTERIUM INDOLOGENES; COMPUTER PROGRAM; CONTROLLED STUDY; CYSTIC FIBROSIS; ELIZABETHKINGIA MENINGOSEPTICA; GENE SEQUENCE; GENUS; GRAM NEGATIVE BACTERIUM; HERBASPIRILLUM; HERBASPIRILLUM SEROPEDICAE; INTERMETHOD COMPARISON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR DIAGNOSIS; NONFERMENTING GRAM NEGATIVE BACILLI; NONHUMAN; PANDORAEA; PANTOEA AGGLOMERANS; PRIORITY JOURNAL; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PSEUDOALCALIGENES; RALSTONIA; RALSTONIA MANNITOLILYTICA; ROSEOMONAS; SPHINGOMONAS ROSEIFLAVA; STANDARD; STENOTROPHOMONAS MALTOPHILIA;

BACTERIA, AEROBIC; BACTERIOLOGICAL TECHNIQUES; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IOWA; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS;

BACILLI (CLASS); NEGIBACTERIA;

EID: 84862071299     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00330-12     Document Type: Article

References (28)

1. Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. 2010. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J. Clin. Microbiol. 48:1549-1554.
2. Cherkaoui A, et al. 2010. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J. Clin. Microbiol. 48:1169-1175.
3. Clarridge JE. 2004. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin. Microbiol. Rev. 17:840-862.
4. Clinical and Laboratory Standards Institute. 2008. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. CLSI document MM18-A. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Cloud JL, et al. 2010. Comparison of traditional phenotypic identification methods with partial 5′ 16S rRNA gene sequencing for species-level identification of nonfermenting gram-negative bacilli. J. Clin. Microbiol. 48:1442-1444.
6. Cystic Fibrosis Foundation. 2011. Patient registry 2010. Annual data report. Cystic Fibrosis Foundation, Bethesda, MD.
7. Degand N, et al. 2008. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gramnegative bacilli isolated from cystic fibrosis patients. J. Clin. Microbiol. 46:3361-3367.
8. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. 2011. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J. Clin. Microbiol. 49:1614-1616.
9. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951. (Pubitemid 37267172)
10. Goss CH, et al. 2004. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 59:955-959. (Pubitemid 39490780)
11. Hauser AR, Jain M, Bar-Meir M, McColley SA. 2011. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin. Microbiol. Rev. 24:29-70.
12. Justesen US, et al. 2011. Species identification of clinical isolates of anaerobic bacteria: a comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems. J. Clin. Microbiol. 49:4314-4318.
13. Lay JO. 2001. MALDI-TOF mass spectrometry of bacteria. Mass Spectrom. Rev. 20:172-194. (Pubitemid 34151742)
14. LiPuma JJ. 2010. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23:299 -323.
15. LiPuma JJ, Currie BJ, Peacock SJ, VanDamme PAR. 2011. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax, p 692-713. In Versalovic J, et al (ed), Manual of clinical microbiology, 10th ed. ASM Press, Washington, DC.
16. LiPuma JJ, et al. 1999. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J. Clin. Microbiol. 37:3167-3170.
17. Liu L, et al. 2002. Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from cystic fibrosis patients. J. Clin. Microbiol. 40:1210-1213. (Pubitemid 34279877)
18. Mahenthiralingam E, et al. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38:3165-3173.
19. Marko DC, et al. 2011. Abstr. 111th Gen. Meet. Am. Soc. Microbiol., abstr C-3352.
20. Neville SA, et al. 2011. Utility of matrix-assisted laser desorption ionization-time of flight mass spectrometry following introduction for routine laboratory bacterial identification. J. Clin. Microbiol. 49:2980-2984.
21. Reik R, Spilker T, LiPuma JJ. 2005. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J. Clin. Microbiol. 43:2926-2928. (Pubitemid 40827976)
22. Riordan JR, et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073. (Pubitemid 19231814)
23. Rowe SM, Miller S, Sorscher EJ. 2005. Cystic fibrosis. N. Engl. J. Med. 352:1992.
24. Saffert RT, et al. 2011. Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J. Clin. Microbiol. 49:887- 892.
25. van Veen SQ, Claas EC, Kuijper EJ. 2010. High throughput identification of bacteria and yeast by matrix-assisted laser desorption ionizationtime of flight mass spectrometry in conventional medical microbiology laboratories. J. Clin. Microbiol. 48:900-907.
26. Von Konig CW, Riffelmann M, Coenye T. 2011. Bordetella and related genera, p 739-750. In Versalovic J, et al (ed), Manual of clinical microbiology, 10th ed. ASM Press, Washington, DC.
27. Waters V, et al. 2011. Stenotrophomonas maltophilia in cystic fibrosis. Am. J. Respir. Crit. Care Med. 183:635-640.
28. Welsh MJ, Smith AE. 1993. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251-1254. (Pubitemid 23201140)